Enzo Biochem Files 8-K
| Field | Detail |
|---|---|
| Company | Enzo Biochem Inc |
| Form Type | 8-K |
| Filed Date | Apr 22, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 8-k
TL;DR
Enzo Biochem filed a routine 8-K on 4/22/25. No major news.
AI Summary
Enzo Biochem, Inc. filed an 8-K on April 22, 2025, reporting on other events and financial statements. The filing does not contain specific financial details or significant corporate actions beyond the standard reporting requirements.
Why It Matters
This filing indicates Enzo Biochem is meeting its regulatory reporting obligations. Investors should review the full document for any material updates not summarized here.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report and does not appear to contain any new material information that would immediately impact the company's risk profile.
Key Players & Entities
- Enzo Biochem, Inc. (company) — Registrant
- April 22, 2025 (date) — Date of earliest event reported
- New York (location) — State of incorporation
- 631-755-5500 (phone_number) — Registrant's telephone number
FAQ
What is the purpose of this 8-K filing for Enzo Biochem, Inc.?
This 8-K filing serves as a current report for Enzo Biochem, Inc., covering 'Other Events' and 'Financial Statements and Exhibits' as of April 22, 2025.
What is Enzo Biochem, Inc.'s principal executive office address?
Enzo Biochem, Inc.'s principal executive offices are located at 21 Executive Blvd., Farmingdale, New York 11735.
What is the telephone number for Enzo Biochem, Inc.?
The registrant's telephone number, including area code, is (631) 755-5500.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on April 22, 2025.
What is Enzo Biochem, Inc.'s state of incorporation?
Enzo Biochem, Inc. is incorporated in New York.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 22, 2025 regarding ENZO BIOCHEM INC.